Rapid Trial Bio

Rapid Trial Bio (RTB) is an international startup company established in 2025 with the goal of connecting smaller early-stage funded biotech and pharmaceutical companies, starting in the European Union (EU) and North America, with niche and local contract research organizations (CROs) in the Asian region. These CROs offer competitive clinical phase pricing without compromising the quality and reliability provided by well-established multinational CROs. The company's foundation stems from the founders' extensive connections with venture capitalists and investment groups, leveraging their experience as portfolio manager and business intelligence analyst. Additionally, their substantial network within the Asian CRO market played an important role in the development of the startup.